8JZM

The inhibitor of Toll-like receptor signaling o-vanillin binds covalently to MAL/TIRAP Lys-210

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
2	2D 1H-13C HSQC aliphatic	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
3	2D 1H-13C HSQC aromatic	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
4	3D 1H-13C NOESY aliphatic	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
5	3D 1H-13C NOESY aromatic	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
6	3D 1H-15N NOESY	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
7	3D HNCA	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
8	3D HN(CO)CA	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
9	3D HNCACB	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
10	3D HCCH-TOCSY	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
11	3D CBCA(CO)NH	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
12	3D HBHA(CO)NH	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900
13	3D HNCO	106 uM [U-100% 13C; U-100% 15N] MAL-TIR, 10 mM sodium chloride, 10 mM HEPES, 5 % v/v [U-100% 2H] D2O, 95 % v/v H2O	95% H2O/5% D2O	10 mM	7.5	1 atm	298	Bruker AVANCE III 900

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	900

NMR Refinement
Method	Details	Software
torsion angle dynamics		CYANA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CcpNmr Analysis		Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, and Laue ED.
2	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
3	refinement	CYANA		Guntert, Mumenthaler and Wuthrich
4	peak picking	CcpNmr Analysis		Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, and Laue ED.

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.